Perspective: The RNA exosome, cytokine gene regulation and links to autoimmunity

Cytokine

Volumn 74, Issue 2, 2015, Pages 175-180

  Blin, Juliana ^a,b   Fitzgerald, Katherine A ^b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; Cytokines; Exosome; Innate immunity; RNA sensors

Indexed keywords

CYTOKINE; RNA; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSENSOR; COMPLEX FORMATION; CYTOKINE PRODUCTION; DISEASE ACTIVITY; EXOSOME; GENE CONTROL; GENE FUNCTION; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; RNA PROCESSING;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; GENE EXPRESSION REGULATION; HUMANS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SELF TOLERANCE;

EID: 84949623796     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.03.005     Document Type: Review

References (44)

1. Lykke-Andersen S., Brodersen D.E., Jensen T.H. Origins and activities of the eukaryotic exosome. J Cell Sci 2009, 122(Pt 10):1487-1494.
2. Chlebowski A., et al. RNA decay machines: the exosome. Biochim Biophys Acta 2013, 1829(6-7):552-560.
3. Mitchell P., et al. The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'->5' exoribonucleases. Cell 1997, 91(4):457-466.
4. Allmang C., et al. The yeast exosome and human PM-Scl are related complexes of 3'->5' exonucleases. Genes Dev 1999, 13(16):2148-2158.
5. Brouwer R., Pruijn G.J., van Venrooij W.J. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res 2001, 3(2):102-106.
6. Fabre A., Badens C. Human Mendelian diseases related to abnormalities of the RNA exosome or its cofactors. Intractable Rare Dis Res 2014, 3(1):8-11.
7. Chen C.Y., et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001, 107(4):451-464.
8. Eckard S.C., et al. The SKIV2L RNA exosome limits activation of the RIG-I-like receptors. Nat Immunol 2014, 15(9):839-845.
9. Seko Y., et al. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 2006, 5(5):299-305.
10. Stumpo D.J., Lai W.S., Blackshear P.J. Inflammation: cytokines and RNA-based regulation. Wiley Interdiscip Rev RNA 2010, 1(1):60-80.
11. Kawasaki T., Kawai T., Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 2011, 243(1):61-73.
12. Schneider C., Tollervey D. Threading the barrel of the RNA exosome. Trends Biochem Sci 2013, 38(10):485-493.
13. Liu Q., Greimann J.C., Lima C.D. Reconstitution, activities, and structure of the eukaryotic RNA exosome. Cell 2006, 127(6):1223-1237.
14. Wasmuth E.V., Januszyk K., Lima C.D. Structure of an Rrp6-RNA exosome complex bound to poly(A) RNA. Nature 2014, 511(7510):435-439.
15. LaCava J., et al. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 2005, 121(5):713-724.
16. Halbach F., et al. The yeast ski complex: crystal structure and RNA channeling to the exosome complex. Cell 2013, 154(4):814-826.
17. Tomecki R., et al. The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L. EMBO J 2010, 29(14):2342-2357.
18. Sloan K.E., Schneider C., Watkins N.J. Comparison of the yeast and human nuclear exosome complexes. Biochem Soc Trans 2012, 40(4):850-855.
19. Doma M.K., Parker R. RNA quality control in eukaryotes. Cell 2007, 131(4):660-668.
20. Guo X., et al. The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci USA 2007, 104(1):151-156.
21. Makino D.L., Halbach F., Conti E. The RNA exosome and proteasome: common principles of degradation control. Nat Rev Mol Cell Biol 2013, 14(10):654-660.
22. Mullen T.E., Marzluff W.F. Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'. Genes Dev 2008, 22(1):50-65.
23. Orban T.I., Izaurralde E. Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 2005, 11(4):459-469.
24. Wu J., Chen Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014, 32:461-488.
25. Carpenter S., et al. Post-transcriptional regulation of gene expression in innate immunity. Nat Rev Immunol 2014, 14(6):361-376.
26. Schoenberg D.R., Maquat L.E. Regulation of cytoplasmic mRNA decay. Nat Rev Genet 2012, 13(4):246-259.
27. Mukherjee D., et al. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 2002, 21(1-2):165-174.
28. Brooks S.A., Blackshear P.J. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta 2013, 1829(6-7):666-679.
29. Deleault K.M., Skinner S.J., Brooks S.A. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 2008, 45(1):13-24.
30. Taylor G.A., et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4(5):445-454.
31. Esnault S., et al. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J Immunol 2006, 177(10):6999-7006.
32. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol 2002, 23(8):403-408.
33. Katsanou V., et al. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol Cell Biol 2009, 29(10):2762-2776.
34. Katsanou V., et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 2005, 19(6):777-789.
35. Gurtler C., Bowie A.G. Innate immune detection of microbial nucleic acids. Trends Microbiol 2013, 21(8):413-420.
36. Lau C.M., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005, 202(9):1171-1177.
37. Deane J.A., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007, 27(5):801-810.
38. Stetson D.B., et al. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134(4):587-598.
39. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009, 18(R2):R130-R136.
40. Rice G.I., et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009, 41(7):829-832.
41. Cho J.A., et al. The unfolded protein response element IRE1alpha senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe 2013, 13(5):558-569.
42. Kato H., Fujita T. Autoimmunity caused by constitutive activation of cytoplasmic viral RNA sensors. Cytokine Growth Factor Rev 2014, 25(6):739-743.
43. Crampton S.P., Bolland S. Spontaneous activation of RNA-sensing pathways in autoimmune disease. Curr Opin Immunol 2013, 25(6):712-719.
44. Fernando M.M., et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007, 3(11):e192.